Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.

Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.

Item

http://www.wikidata.org/entity/Q53691286

Q53691286

about

Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.

Item

http://www.wikidata.org/entity/Q53691286

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Neogambogic Acid Suppresses Re ...... -Derived Monocyte/Macrophages.

@en

Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand

@nl

type

Item

label

Neogambogic Acid Suppresses Re ...... -Derived Monocyte/Macrophages.

@en

Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand

@nl

prefLabel

Neogambogic Acid Suppresses Re ...... -Derived Monocyte/Macrophages.

@en

Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand

@nl

P1476

Neogambogic Acid Suppresses Re ...... -Derived Monocyte/Macrophages.

@en

P2093

Dong-Dong Jia

http://www.w3.org/2001/XMLSchema#string

Fang-Fang Wang

http://www.w3.org/2001/XMLSchema#string

Gu Jin

http://www.w3.org/2001/XMLSchema#string

Hai-Chao Xu

http://www.w3.org/2001/XMLSchema#string

Tao Li

http://www.w3.org/2001/XMLSchema#string

Yong Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Differentiation of Bone Marrow Mesenchymal Stem Cells in Osteoblasts and Adipocytes and its Role in Treatment of Osteoporosis

Osteoporosis treatment: a missed opportunity.

Factors and mechanisms involved in the coupling from bone resorption to formation: how osteoclasts talk to osteoblasts.

Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology.

Basic science for the clinician 39: NF-kappaB-function, activation, control, and consequences.

Osteoporosis: now and the future

The effects of Lycii Radicis Cortex on RANKL-induced osteoclast differentiation and activation in RAW 264.7 cells

Gambogenic acid inhibits LPS-simulated inflammatory response by suppressing NF-κB and MAPK in macrophages.

FTY-720P Suppresses Osteoclast Formation by Regulating Expression of Interleukin-6 (IL-6), Interleukin-4 (IL-4), and Matrix Metalloproteinase 2 (MMP-2).

Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway

P304

2569-2577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.909651

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29698379

http://www.w3.org/2001/XMLSchema#string

P921

NF-κB

P932

5939603

http://www.w3.org/2001/XMLSchema#string

Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.

about

Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932